Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Evansville, Indiana 47710


Purpose:

Primary Objective: The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.


Study summary:

The total duration of the study for each subject will be approximately 5 weeks (screening period from Day -28 to Day -2, treatment period of 3 days, and follow-up call on Day 5).


Criteria:

Inclusion criteria : - Healthy male and female subjects, 18 to 55 years of age, inclusive. - Normal smell and taste ability to discriminate odor and flavor differences. Exclusion criteria: - Poor metabolizer phenotype status for CYP2D6 (predicted based on genotype). - Subject who has smoked within 3 months of inclusion. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.


NCT ID:

NCT02422654


Primary Contact:

Study Director
Clinical Sciences & Operations
Sanofi


Backup Contact:

N/A


Location Contact:

Evansville, Indiana 47710
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.